{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:08:51Z","timestamp":1788754131336,"version":"build-2803163510"},"reference-count":81,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pathogens and Global Health"],"published-print":{"date-parts":[[2022,2,17]]},"DOI":"10.1080\/20477724.2021.1972663","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T15:40:34Z","timestamp":1632757234000},"page":"85-98","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":41,"title":["Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations"],"prefix":"10.1080","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-581X","authenticated-orcid":false,"given":"Federico","family":"Martin\u00f3n-Torres","sequence":"first","affiliation":[{"name":"Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP, Instituto De Investigaci\u00f3n Sanitaria De Santiago and Universidad De Santiago De Compostela (Usc), Santiago de Compostela, Galicia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0716-3174","authenticated-orcid":false,"given":"Muhamed-Kheir","family":"Taha","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Invasive Bacterial Infections Unit, National Reference Centre for Meningococci and Haemophilus Influenza, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Knuf","sequence":"additional","affiliation":[{"name":"Klinik F\u00fcr Kinder- Und Jugendmedizin, Worms, Germany and Pediatric Infectious Diseases, University Medicine, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1987-363X","authenticated-orcid":false,"given":"Victoria","family":"Abbing-Karahagopian","sequence":"additional","affiliation":[{"name":"GSK, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-9260","authenticated-orcid":false,"given":"Michele","family":"Pellegrini","sequence":"additional","affiliation":[{"name":"GSK, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0683-6055","authenticated-orcid":false,"given":"Rafik","family":"Bekkat-Berkani","sequence":"additional","affiliation":[{"name":"GSK, Rockville, MD, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0369-7715","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Abitbol","sequence":"additional","affiliation":[{"name":"GSK, Rueil-Malmaison, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1557520"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.063"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.03.041"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.079"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.020"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0213-2"},{"key":"cit0007","volume-title":"Plotkin\u2019s vaccines: Philadelphia, Elsevier, 2018. p. 619\u2013643.","author":"Harrison LH"},{"key":"cit0008","first-page":"23","volume":"66","author":"Pollard AJ","year":"2001","journal-title":"Methods Mol Med"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101521"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.067"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00299-7"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7341.809"},{"issue":"3","key":"cit0013","first-page":"220","volume":"5","author":"Trotter CL","year":"2002","journal-title":"Commun Dis Public Health"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00529-09"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1086\/527401"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39563.545255.AE"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.1.1700818"},{"key":"cit0018","unstructured":"Joint Committee on Vaccination and Immunisation (JCVI). Minute of the meeting on 4 February 2015. [cited 2021 Feb 2]. Available from: http:\/\/app.box.com\/s\/iddfb4ppwkmtjusir2tc\/file\/229171832189."},{"key":"cit0019","unstructured":"Public Health England. Historical vaccine development and introduction of routine vaccine programmes in the UK. 2019. [cited 2021 Feb 2]. Available from: http:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/816174\/Vaccine_Timeline_2019.pdf."},{"key":"cit0020","unstructured":"Public Health England. Immunisation against infection disease. Chapter 22. Meningococcal. 2016. [cited 2021 Jan 21]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/554011\/Green_Book_Chapter_22.pdf."},{"key":"cit0021","unstructured":"European Centre for Disease Prevention and Control. Disease data from ECDC Surveillance Atlas for meningococcal disease. 2020 Feb. [cited 2021 Feb 2]. Available from: http:\/\/www.ecdc.europa.eu\/en\/meningococcal-disease\/surveillance-and-disease-data\/atlas."},{"key":"cit0022","unstructured":"Public Health England. Invasive meningococcal disease in England: annual laboratory confirmed reports for epidemiological year 2019 to 2020. 2021 Jan. Available from: http:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/951142\/hpr0121_imd-ann.pdf."},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.06.019"},{"issue":"23","key":"cit0024","first-page":"1132","volume":"147","author":"De Greeff SC","year":"2003","journal-title":"Ned Tijdschr Geneeskd"},{"key":"cit0025","unstructured":"National Institute for Public Health and the Environment. The National Immunisation Programme in the Netherlands. Developments in 2012. RIVM report 201001002\/2012. [cited 2021 Feb 2]. Available from: http:\/\/www.rivm.nl\/bibliotheek\/rapporten\/201001002.pdf."},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000195594.41449.c6"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu601"},{"key":"cit0028","unstructured":"National Institute for Public Health and the Environment. The national immunisation programme in the Netherlands. Surveillance and developments in 2018-2019. 2019. [cited 2021 Feb 2]. Available from: http:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2019-0193.pdf."},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-8244(98)00120-5"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01704.x"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-019-03668-y"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1078951"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.06.002"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.12.30176"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819000396"},{"key":"cit0036","unstructured":"Health Protection Surveillance Center. Bacterial meningitis\/Meningococcal disease. 2019 Sept. [cited 2021 Feb 2]. Available from: http:\/\/www.hpsc.ie\/a-z\/vaccinepreventable\/bacterialmeningitis\/factsheets\/#:~:text=Group%20C%3A%20The%20meningococcal%20group,2%2C%204%20and%206%20months"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2015-310215"},{"key":"cit0038","first-page":"1","author":"Taha MK","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"cit0039","unstructured":"Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad CyBS. Grupo de trabajo vacunaci\u00f3n frente a EMI de la Ponencia de Programa y Registro de Vacunaciones. Recomendaciones de vacunaci\u00f3n frente a enfermedad meningoc\u00f3cica invasiva. 2019 March. [cited 2021 Feb 2]. Available from: http:\/\/www.mscbs.gob.es\/va\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/Recomendaciones_Vacunacion_Meningococo.pdf."},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.007"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.14.1800245"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.06.010"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2017.10.015"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz578"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819002152"},{"key":"cit0046","unstructured":"European Centre for Disease Prevention and Control. Invasive meningococcal disease. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC. 2019. [cited 2021 Feb 2]. Available from: http:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/AER_for_2017-invasive-meningococcal-disease.pdf."},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.3201\/eid2307.170236"},{"key":"cit0048","unstructured":"Health Ministry Italy. Piano nazionale prevenzione vaccinale PNPV 2017-2019. 2017 Jan. [cited 2021 Feb 2]. Available from: http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2571_allegato.pdf."},{"key":"cit0049","unstructured":"National Immunisation Office. MenACWY schools immunisation program. 2020 Aug. [cited 2021 Feb 2]. Available from: http:\/\/www.hse.ie\/eng\/health\/immunisation\/pubinfo\/schoolprog\/menacwy\/."},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2015-308928"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00217-0"},{"key":"cit0052","unstructured":"Department of Health and Social Care, Public Health England. JCVI position statement on use of Bexsero meningococcal B vaccine in the UK. 2014 March. [cited 2021 Feb 22]. Available from: http:\/\/www.gov.uk\/government\/publications\/meningococcal-b-vaccine-jcvi-position-statement."},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901229"},{"issue":"2","key":"cit0054","first-page":"88","volume":"87","year":"2018","journal-title":"Ulster Med J"},{"issue":"4","key":"cit0055","first-page":"1","volume":"30","author":"Signorelli C","year":"2018","journal-title":"Ann Ig"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030469"},{"key":"cit0057","unstructured":"National Immunisation Office. Primary childhood immunisation schedule. Disease vaccines prevent - Meningococcal B. 2019 Jan. Available from: http:\/\/www.hse.ie\/eng\/health\/immunisation\/pubinfo\/pcischedule\/vpds\/menb\/."},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00196-18"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.20449"},{"key":"cit0060","unstructured":"Office of the Secretary of State for Health, Portugal. Despacho n.\u00ba 12434\/2019. Diario da Republica. Series 2, 2019. Available from: https:\/\/dre.pt\/application\/conteudo\/127608823."},{"key":"cit0061","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Strat\u00e9gie de vaccination pour la pr\u00e9vention des infections invasives \u00e0 m\u00e9ningocoques: Le s\u00e9rogroupe B et la place de Bexsero\u00ae. June 2021. [cited 2021 Jul 19]. Available from: http:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-06\/strategie_de_vaccination_pour_la_prevention_des_infections_invasives_a_meningocoques_le_serogroupe_b_et_la_place_de_bexsero.pdf."},{"key":"cit0062","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2020 global summary. 2020 Oct. [cited 2021 Feb 2]. Available from: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/schedules."},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.10.029"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.11.001"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy257"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1636"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2016.1130628"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.007"},{"key":"cit0069","unstructured":"European Medicines Agency. Bexsero: summary of product characteristics. 2020 Jul. [cited 2021 Feb 2]. Available from: http:\/\/www.ema.europa.eu\/en\/documents\/product-information\/bexsero-epar-product-information_en.pdf."},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.10.096"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.001"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.016"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.07.034"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.09.050"},{"key":"cit0075","author":"Biolchi A","year":"2020","journal-title":"Infect Dis Ther"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.022"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008602"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1244"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900236"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1253"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz297"}],"container-title":["Pathogens and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20477724.2021.1972663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T06:44:43Z","timestamp":1647413083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20477724.2021.1972663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,17]]}},"alternative-id":["10.1080\/20477724.2021.1972663"],"URL":"https:\/\/doi.org\/10.1080\/20477724.2021.1972663","relation":{},"ISSN":["2047-7724","2047-7732"],"issn-type":[{"value":"2047-7724","type":"print"},{"value":"2047-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ypgh20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ypgh20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}